Chinese startup develops PCR testing equipment for household use
Product gives accurate COVID-19 test results without special training
Ustar has developed PCR testing equipment for household use. (Phot courtesy of the company)
BEIJING -- Ustar, a Chinese point of care (POC) startup that designs molecular diagnostic systems, has raised about 300 million yuan ($2.6 million) in a Series E+ funding round.
The investment was led by CPE Yuanfeng. Current Ustar shareholder Oriental Fortune Capital also made an additional investment.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapterFind out more
Free access for everyone - Sep. 30